• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌重复活检中的检测:盆腔相控阵多参数 MRI 能否替代饱和活检?

Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy?

机构信息

Urology Unit, Cannizzaro Hospital, via Messina 829, Catania, Italy.

出版信息

Anticancer Res. 2013 Mar;33(3):1195-9.

PMID:23482802
Abstract

AIM

Magnetic resonance imaging (MRI) accuracy in prostate cancer (PCa) diagnosis in men submitted to saturation prostate biopsy (SPBx) was evaluated.

MATERIALS AND METHODS

From June 2011 to December 2012, 78 patients (median 63 years) underwent repeat SPBx (median 28 cores). Multiparametric MRI using a 3 Tesla pelvic phased-array coil was performed before SPBx and lesions suspicious for PCa were submitted to additional targeted biopsies.

RESULTS

A T1c PCa was found in 32 (41%) cases. SPBx vs. MRI-suspicious targeted biopsy diagnosed 28 (87.5%) vs. 26 (81.2%) PCa missing four (12.5%) and six (18.8%) cancers localized in the anterior zone and in the lateral margin of the prostate, respectively; moreover, MRI diameter lesions correlated with PCa diagnosis and Gleason score (p<0.05).

CONCLUSION

Multiparametric MRI improved SPBx accuracy in diagnosing PCa of the anterior zone; moreover, suspicious areas >10 mm resulted as highly predictive of cancer (about 70% of the cases).

摘要

目的

评估磁共振成像(MRI)在接受饱和前列腺活检(SPBx)的男性前列腺癌(PCa)诊断中的准确性。

材料和方法

2011 年 6 月至 2012 年 12 月,78 例患者(中位年龄 63 岁)接受重复 SPBx(中位 28 个核心)。在 SPBx 前进行多参数 MRI,使用 3T 盆腔相控阵线圈,对可疑 PCa 的病变进行额外的靶向活检。

结果

32 例(41%)发现 T1c PCa。SPBx 与 MRI 可疑靶向活检诊断出 28 例(87.5%)和 26 例(81.2%)PCa,分别遗漏了 4 例(12.5%)和 6 例(18.8%)位于前列腺前区和侧缘的癌症;此外,MRI 直径病变与 PCa 诊断和 Gleason 评分相关(p<0.05)。

结论

多参数 MRI 提高了 SPBx 诊断前区 PCa 的准确性;此外,可疑区域>10mm 高度提示癌症(约 70%的病例)。

相似文献

1
Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy?前列腺癌重复活检中的检测:盆腔相控阵多参数 MRI 能否替代饱和活检?
Anticancer Res. 2013 Mar;33(3):1195-9.
2
Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?3特斯拉盆腔相控阵多参数磁共振成像能否避免血清前列腺特异抗原(PSA)<10 ng/mL患者进行不必要的重复前列腺穿刺活检?
Clin Genitourin Cancer. 2015 Feb;13(1):e27-30. doi: 10.1016/j.clgc.2014.06.013. Epub 2014 Jun 21.
3
Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy.3特斯拉盆腔相控阵多参数磁共振成像在重复活检诊断前列腺癌中的准确性
Arch Ital Urol Androl. 2014 Dec 30;86(4):336-9. doi: 10.4081/aiua.2014.4.336.
4
Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the reevaluation of biopsy microfocal tumor.多参数盆腔MRI在活检微灶性肿瘤重新评估中诊断临床显著性前列腺癌的准确性。
Anticancer Res. 2015 Jan;35(1):395-9.
5
Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.饱和前列腺穿刺活检以及初次和重复评估时的前列腺癌检测
Urology. 2007 Dec;70(6):1131-5. doi: 10.1016/j.urology.2007.07.068.
6
Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?当进行饱和活检时,定量组织学检查对预测非器官局限性前列腺癌是否有用?
Urology. 2008 Dec;72(6):1198-202. doi: 10.1016/j.urology.2008.05.045.
7
Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.经直肠饱和前列腺穿刺活检作为初始活检策略的潜在益处:降低未来活检发现显著癌症的可能性。
Urology. 2014 Apr;83(4):714-8. doi: 10.1016/j.urology.2013.12.029.
8
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.前列腺多参数磁共振成像可以提高前列腺特异性抗原水平升高且既往前列腺活检阴性患者的尿前列腺癌抗原 3 检测的预测价值。
BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.
9
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.初始活检前磁共振成像的作用:比较磁共振成像靶向与系统活检在检出显著前列腺癌中的作用。
BJU Int. 2011 Oct;108(8 Pt 2):E171-8. doi: 10.1111/j.1464-410X.2011.10112.x. Epub 2011 Mar 22.
10
Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.纳入主动监测方案的男性患者在确诊性活检时显著癌症的检出率:20针活检与30针活检对比MRI/TRUS融合前列腺活检。
Arch Ital Urol Androl. 2016 Dec 30;88(4):300-303. doi: 10.4081/aiua.2016.4.300.

引用本文的文献

1
Ga-PSMA PET/CT and Prostate Cancer Diagnosis: Which SUVmax Value?镓-PSMA PET/CT 与前列腺癌诊断:哪个 SUVmax 值?
In Vivo. 2023 May-Jun;37(3):1318-1322. doi: 10.21873/invivo.13211.
2
Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer.认知磁共振成像-超声融合经会阴靶向活检联合随机活检在前列腺癌检测中的应用
World J Clin Cases. 2021 Dec 26;9(36):11183-11192. doi: 10.12998/wjcc.v9.i36.11183.
3
Multiparametric MRI SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance.
多参数 MRI 对主动监测中临床显著前列腺癌的诊断准确性:SelectMDx 研究
In Vivo. 2020 Jan-Feb;34(1):393-396. doi: 10.21873/invivo.11786.
4
Biomarkers for detecting prostate cancer: Protocol for an umbrella review with integrated network meta-analysis.用于检测前列腺癌的生物标志物:一项整合网络荟萃分析的伞状综述方案。
Medicine (Baltimore). 2019 Jul;98(30):e16517. doi: 10.1097/MD.0000000000016517.
5
Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.用于检测前列腺癌的前列腺磁共振成像(MRI),无论是否进行MRI靶向活检及系统活检。
Cochrane Database Syst Rev. 2019 Apr 25;4(4):CD012663. doi: 10.1002/14651858.CD012663.pub2.
6
Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.多参数磁共振成像表观扩散系数(ADC)在诊断具有临床意义的前列腺癌中的准确性
In Vivo. 2017 May-Jun;31(3):415-418. doi: 10.21873/invivo.11075.
7
Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline.基于证据的多参数磁共振成像在前列腺癌诊断中的指南推荐:安大略癌症护理临床实践指南。
Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E1-E7. doi: 10.5489/cuaj.3968. Epub 2017 Jan 12.
8
Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?在对接受主动监测的男性进行重新评估时,MRI/TRUS融合靶向活检能否取代饱和式前列腺活检?
World J Urol. 2016 Sep;34(9):1249-53. doi: 10.1007/s00345-015-1749-3. Epub 2015 Dec 23.
9
Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?初次及重复评估时的前列腺前叶活检:对于检测显著前列腺癌是否有用?
Int Braz J Urol. 2015 Sep-Oct;41(5):844-8. doi: 10.1590/S1677-5538.IBJU.2014.0234.
10
Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.前列腺前部癌(APC)的临床病理特征,包括与既往活检病理的相关性。
Med Oncol. 2015 Nov;32(11):249. doi: 10.1007/s12032-015-0693-9. Epub 2015 Oct 6.